Balyasny Asset Management
THC icon

Balyasny Asset Management’s Tenet Healthcare THC Stock Holding History

Balyasny Asset Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Sell
1,400
-1,000
-42% -$184K ﹤0.01% 2747
2026
Q1 		$453K Sell
2,400
-4,400
-65% -$927K ﹤0.01% 2406
2025
Q4 		$1.35M Buy
6,800
+5,700
+518% +$1.15M ﹤0.01% 2054
2025
Q3 		$223K Sell
1,100
-18,900
-95% -$3.35M ﹤0.01% 2693
2025
Q2 		$3.52M Buy
+20,000
New +$3.01M 0.01% 1464
2020
Q4 		– Sell
-50,000
Closed -$1.23M – 1694
2020
Q3 		$1.23M Buy
+50,000
New +$1.28M 0.01% 954

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Balyasny Asset Management's THC Position: Q2 2026 in Review

Balyasny Asset Management increased its Tenet Healthcare (THC) stake by 55% in Q2 2026, buying an estimated $118K and bringing the position to 1,807 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #2673.

Balyasny Asset Management first reported a position in THC in Q2 2013 and has held it in 39 quarters since. The position peaked at $70.3M in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Balyasny Asset Management held 1,807 shares of Tenet Healthcare worth $338K as of Q2 2026.
  • Balyasny Asset Management bought 644 Tenet Healthcare shares in Q2 2026, an estimated $118K.
  • Tenet Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2673 holding.
  • Balyasny Asset Management first reported a position in Tenet Healthcare in Q2 2013 and has held it in 39 quarters since.
  • Balyasny Asset Management's Tenet Healthcare position peaked at $70.3M in Q3 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.